Seems they had a solid share structure and that's about to be wiped away.
The next quarter here looks pretty bad imo.
See no revenues, high debt and alotta diluting all about to take place (already is).
But they have somewhat of a breakthrough in ms pain relief??
Just like a lot of stocks, time to buy is early next year after a lousy quarter report is filed....